scholarly journals 337. CRISPR/Cas9 Mediated Highly Efficient Genome Engineering in Mouse Embryos

2015 ◽  
Vol 23 ◽  
pp. S135
Author(s):  
Khurshida Begum ◽  
Bert W. O'Malley ◽  
Francesco J. DeMayo ◽  
Paul Overbeek
2014 ◽  
Vol 4 (1) ◽  
Author(s):  
Akihiro Yasue ◽  
Silvia Naomi Mitsui ◽  
Takahito Watanabe ◽  
Tetsushi Sakuma ◽  
Seiichi Oyadomari ◽  
...  

2014 ◽  
Vol 5 (1) ◽  
Author(s):  
Daniel Sommer ◽  
Annika E. Peters ◽  
Tristan Wirtz ◽  
Maren Mai ◽  
Justus Ackermann ◽  
...  

2018 ◽  
Vol 4 (1) ◽  
Author(s):  
Ikuko Watakabe ◽  
Hisashi Hashimoto ◽  
Yukiko Kimura ◽  
Saori Yokoi ◽  
Kiyoshi Naruse ◽  
...  

Author(s):  
Tomomi Aida ◽  
Jonathan J. Wilde ◽  
Lixin Yang ◽  
Yuanyuan Hou ◽  
Mengqi Li ◽  
...  

SummaryGenome editing has transformed biomedical science, but is still unpredictable and often induces undesired outcomes. Prime editing (PE) is a promising new approach due to its proposed flexibility and ability to avoid unwanted indels. Here, we show highly efficient PE-mediated genome editing in mammalian zygotes. Utilizing chemically modified guideRNAs, PE efficiently introduced 10 targeted modifications including substitutions, deletions, and insertions across 6 genes in mouse embryos. However, we unexpectedly observed a high frequency of undesired outcomes such as large deletions and found that these occurred more often than pure intended edits across all of the edits/genes. We show that undesired outcomes result from the double-nicking PE3 strategy, but that omission of the second nick largely ablates PE function. However, sequential double-nicking with PE3b, which is only applicable to a fraction of edits, eliminated undesired outcomes. Overall, our findings demonstrate the promising potential of PE for predictable, flexible, and highly efficient in vivo genome editing, but highlight the need for improved variations of PE before it is ready for widespread use.


2019 ◽  
Vol 10 (1) ◽  
Author(s):  
Beau R. Webber ◽  
Cara-lin Lonetree ◽  
Mitchell G. Kluesner ◽  
Matthew J. Johnson ◽  
Emily J. Pomeroy ◽  
...  

AbstractThe fusion of genome engineering and adoptive cellular therapy holds immense promise for the treatment of genetic disease and cancer. Multiplex genome engineering using targeted nucleases can be used to increase the efficacy and broaden the application of such therapies but carries safety risks associated with unintended genomic alterations and genotoxicity. Here, we apply base editor technology for multiplex gene modification in primary human T cells in support of an allogeneic CAR-T platform and demonstrate that base editor can mediate highly efficient multiplex gene disruption with minimal double-strand break induction. Importantly, multiplex base edited T cells exhibit improved expansion and lack double strand break-induced translocations observed in T cells edited with Cas9 nuclease. Our findings highlight base editor as a powerful platform for genetic modification of therapeutically relevant primary cell types.


2019 ◽  
Vol 10 ◽  
Author(s):  
Yanchun Wang ◽  
Dongshu Wang ◽  
Xiaojing Wang ◽  
Haoxia Tao ◽  
Erling Feng ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document